NCT06484361View on ClinicalTrials.gov

PET/MRI to Stage Prostate Cancer Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Prostate Cancer
Interventions
DRUG

68Ga-PSMA

all patients will undergo PET/MRI with 68Ga-PSMA and 68Ga-RM2 prior to surgical intervention

DRUG

68Ga-RM2

all patients will undergo PET/MRI with 68Ga-PSMA and 68Ga-RM2 prior to surgical intervention

Trial Locations (1)

20132

RECRUITING

IRCCS Ospedale San Raffaele, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER